Don R. Daseke Reports 5.0% Stake in Profound Medical Corp.

TL;DR

**Don R. Daseke just disclosed a 5.0% stake in Profound Medical (PRFN), signaling a notable investor is on board.**

AI Summary

Don R. Daseke, an individual investor, has reported a significant ownership stake in Profound Medical Corp. (NASDAQ: PRFN) as of January 10, 2023. This SC 13G filing indicates that Daseke, acting as part of a group, holds shared voting and dispositive power over 1,600,000 common shares, representing 5.0% of the company's outstanding stock. This matters to investors because a substantial stake by an individual or group can signal confidence in the company's future, potentially influencing stock price and future strategic decisions.

Why It Matters

A 5.0% stake by an individual investor like Don R. Daseke can signal strong belief in Profound Medical Corp.'s prospects and could lead to increased investor attention or potential activist involvement.

Risk Assessment

Risk Level: low — This filing indicates a significant investor's position, which is generally a positive or neutral signal, not an immediate risk.

Analyst Insight

A smart investor would monitor Profound Medical Corp. for any further filings by Don R. Daseke or related parties, as a significant stake by an individual investor can sometimes precede further engagement or a vote of confidence.

Key Numbers

• 1,600,000 — Common Shares (Shares beneficially owned by Don R. Daseke)
• 5.0% — Percentage of Class (Percentage of Profound Medical Corp. common shares owned by Don R. Daseke)
• January 10, 2023 — Date of Event (Date requiring the filing of this statement)

Key Players & Entities

• Don R. Daseke (person) — reporting person and beneficial owner
• Profound Medical Corp. (company) — subject company (issuer)
• 08 Industrial Applications and Services (company) — organization name associated with the subject company
• United States (person) — citizenship of Don R. Daseke
• 1,600,000 (dollar_amount) — number of shares beneficially owned
• 5.0% (dollar_amount) — percentage of class beneficially owned

Forward-Looking Statements

• Don R. Daseke may increase his stake in Profound Medical Corp. if the company's performance improves. (Don R. Daseke) — low confidence, target: 12-2024
• The reported stake could attract more institutional investors to Profound Medical Corp. (Profound Medical Corp.) — medium confidence, target: 06-2024

FAQ

Filing Documents

• sc13g14015prof_12212023.htm (SC 13G) — 79KB
• ex991to13g14015prof_12212023.htm (EX-99.1) — 4KB
• 0000921895-24-000077.txt ( ) — 84KB

(a). Name of Issuer

Item 1(a). Name of Issuer: Profound Medical Corp.

(b). Address of Issuer’s Principal Executive Offices

Item 1(b). Address of Issuer’s Principal Executive Offices: 2400 Skymark Avenue Unit 6 Mississauga, Ontario L4W 5K5

(a). Name of Person Filing

Item 2(a). Name of Person Filing: This statement is filed by Don R. Daseke and Barbara S. Daseke. Each of the foregoing is referred to as a “Reporting Person” and collectively as the “Reporting Persons.” The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed with this Schedule 13G as Exhibit 99.1, pursuant to which they have agreed to file this Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended.

(b). Address of Principal Business Office or, if None, Residence

Item 2(b). Address of Principal Business Office or, if None, Residence: The address of the Reporting Persons is 7901 Windrose Ave., Unit 1504, Plano, Texas 75024.

(c). Citizenship

Item 2(c). Citizenship: Each of the Reporting Persons is a citizen of the United States of America.

(d). Title of Class of Securities

Item 2(d). Title of Class of Securities: Common Shares, no par value (the “Shares”)

(e). CUSIP Number

Item 2(e). CUSIP Number: 74319B502 4 CUSIP No. 74319B502

If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a

Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: /x/ Not applicable. (a) / / Broker or dealer registered under Section 15 of the Exchange Act. (b) / / Bank as defined in Section 3(a)(6) of the Exchange Act. (c) / / Insurance company as defined in Section 3(a)(19) of the Exchange Act. (d) / / Investment company registered under Section 8 of the Investment Company Act. (e) / / An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E). (f) / / An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F). (g) / / A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G). (h) / / A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act. (i) / / A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act. (j) / / Non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J). (k) / / Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____

Ownership

Item 4. Ownership. (a) Amount beneficially owned: As of January 11, 2024, the Reporting Persons beneficially owned 1,105,000 Shares. (b) Percent of class: The aggregate percentage of Shares reported owned herein is based upon 21,366,233 Shares outstanding as of December 27, 2023, as reported in the Issuer’s preliminary prospectus supplement filed with the Securities and Exchange Commission on December 27, 2023. As of January 11, 2024, the Reporting Persons beneficially owned approximately 5.2% of the outstanding Shares. (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: See Cover Pages Items 5-9. (ii) Shared power to vote or to direct the vote: See Cover Pages Items 5-9. 5 CUSIP No. 74319B502 (iii) Sole power to dispose or to direct the disposition of: See Cover Pages Items 5-9. (iv) Shared power to dispose or to direct the disposition of: See Cover Pages Items 5-9.

Ownership of Five Percent or Less of a Class

Item 5. Ownership of Five Percent or Less of a Class. Not Applicable.

Ownership of More than Five Percent on Behalf of Another Person

Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable. Item 7. Identification and Classification of the Subsidiary That Acquired the Security Being Reported on by the Parent Holding Company or Control Person. Not Applicable.

Identification and Classification of Members of the Group

Item 8. Identification and Classification of Members of the Group. See Exhibit 99.1.

Notice of Dissolution of Group

Item 9. Notice of Dissolution of Group. Not Applicable.

Certifications

Item 10. Certifications. By signing below the undersigned certify that, to the best of their knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a–11. 6 CUSIP No. 74319B502 SIGNATURE After reasonable inquiry and to the best of the undersigned’s knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. Date: January 11, 2024 By: /s/ Don R. Daseke Name: Don R. Daseke By: /s/ Barbara S. Daseke Name: Barbara S. Daseke 7

View Full Filing

View this SC 13G filing on SEC EDGAR